Get started
Live feed
INSIDERFilingvia Quantisnow
BioSig Technologies Inc. logo

BioSig Technologies (BSGM) executive Sieckhaus received 295,620 shares

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

John Sieckhaus (executive at BioSig Technologies Inc., BSGM) reported that they received 295,620 shares on May 5, 2023. After these transactions the filing shows 365,620 shares held directly.

Reporting person
Sieckhaus John
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
May 5, 2023Grant or award (A)Common Stock+295,620--365,620 direct

Holdings before and after

  • Common Stock: 70,000 to 365,620 direct

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Sieckhaus report in this BSGM Form 4?

John Sieckhaus (executive at BioSig Technologies Inc., BSGM) reported that they received 295,620 shares on May 5, 2023. After these transactions the filing shows 365,620 shares held directly.

How many BSGM shares does Sieckhaus hold after this filing?

The filing shows 365,620 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for BSGM

Earlier insider filings at BSGM

Quantisnow market dataNASDAQ
BioSig Technologies Inc. logo
BSGM
BioSig Technologies Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Get push alerts for BSGM

Follow BSGM and get a push notification the moment its next story breaks.

Full BSGM profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BSGM (BioSig Technologies Inc.) and more on Quantisnow.